A clinical study to evaluate the comparative efficacy of three Unani drugs in the treatment of Hepatitis B carriers
Phase 2
- Conditions
- Health Condition 1: null- Asymptomatic Hepatitis B Carrier State
- Registration Number
- CTRI/2018/06/014642
- Lead Sponsor
- DG Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects of any Gender aged 20-60 years
2. HBsAg-Positive Asymptomatic Cases
3. Viral Load <20,000 IU/mL
Exclusion Criteria
1. Viral Load: >20,000 IU/mL
2. Active Hepatitis
3. Patients on Immune Suppressants Therapy
4. History of Severe Systemic Disease
5. H/o of Drug or Alcohol Abuse, Chronic Smokers not willing to abstain from smoking during the study period
6. Subjects with known allergies
7. Receiving any other Investigational Product
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method